Back to Search
GREGORY KALEMKERIAN, MD
MD
Medical Oncology Physician
NPI: 1316023278IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301062350(MI)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301062350(MI)
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1985
Research & Publications (20)
Guidelines are never enough: a commentary on "when guidelines are not enough".
PMID 17470876·J Clin Oncol·2007
8-other
Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.
PMID 17265783·J Support Oncol·2007
6-review
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
PMID 11338879·Cancer Invest·2001
3-trial
The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
PMID 18929449·Int J Radiat Oncol Biol Phys·2009
8-other
Time to treatment in patients with stage III non-small cell lung cancer.
PMID 19231108·Int J Radiat Oncol Biol Phys·2009
4-observational
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
PMID 19231104·Int J Radiat Oncol Biol Phys·2009
4-observational
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
PMID 19225720·Invest New Drugs·2009
3-trial
NCCN task force: clinical utility of PET in a variety of tumor types.
PMID 19555588·J Natl Compr Canc Netw·2009
6-review
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.
PMID 18978565·J Thorac Oncol·2008
3-trial
Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer.
PMID 18516296·Neoplasia·2008
7-preclinical
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
PMID 17905467·Lung Cancer·2008
3-trial
Lung lesion doubling times: values and variability based on method of volume determination.
PMID 18068789·Clin Radiol·2008
8-other
Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer.
PMID 18347455·J Neuroophthalmol·2008
5-case
Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy.
PMID 19057272·J Thorac Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1316023278
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile